STOCKHOLM, Sweden, June 17, 2004 (PRIMEZONE) -- As previously announced, following the Federal Circuit's judgment absolving Elekta of all liability in the U.S. patent dispute, Elekta's opponent, Medical Instrumentation and Diagnostics Corporation (Midco), filed a motion to amend its complaint in the District Court and requested that it be allowed to renew its case based on different claims of the patents in question.
On June 15, 2004, the District Court denied Midco's motion and terminated the case.
While it is possible for Midco to file an appeal of this decision and Midco has threatened to file a further suit, Elekta believes that it is unlikely that MIDCO could prevail under any of the claims of the patents.
For further information, please contact:
International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ), Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North America, Elekta, USA Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2004/06/17/20040617BIT20820/wkr0006.pdf
-0-